Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: A case series

Acta Haematologica

Volumn 125, Issue 4, 2011, Pages 210-218

  Zhang, Yanming ^a,b   Wu, Depei ^a   Sun, Aining ^a   Qiu, Huiying ^a   He, Guangsheng ^a   Jin, Zhengming ^a   Tang, Xiaowen ^a   Miao, Miao ^a   Fu, Zhengzheng ^a   Han, Yue ^a  

^a BEIJING HOSPITAL   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biphenotypic leukemia; Cytogenetics; Immunophenotype; Prognosis; Therapy

Indexed keywords

CYTARABINE; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE; PREDNISONE; VINCRISTINE; VINDESINE;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHROMOSOME 11; CHROMOSOME 9; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CYTOGENETICS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LEUKAPHERESIS; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL RATE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78751646023     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000322594     Document Type: Article

References (36)

1. Mirro J, Kitchingman GR, Williams DL, Murphy SB, Zipf TF, Stass SA: Mixed lineage leukemia: the implications for hematopoietic differentiation. Blood 1986;68:597-599.
2. Gale RP, Ben-Bassat I: Hybrid acute leukaemia. Br J Haematol 1987;65:261-264. (Pubitemid 17044665)
3. Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D: Definition of acute biphenotypic leukemia. Haematologica 1997;82:64-66. (Pubitemid 28023490)
4. Weir EG, Ali Ansari-Lari M, Batista DA, Griffin CA, Fuller S, Smith BD, Borowitz MJ: Acute bilineal leukemia: a rare disease with poor outcome. Leukemia 2007;21:2264-2270. (Pubitemid 350011698)
5. Brunning RD, Matutes E, Borowitz M: Acute leukaemias of ambiguous lineage; in Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): WHO Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC, 2001, pp106-107.
6. Borowitz MJ, Béné M-C, Harris NL, Porwit A., Matutes E: Acute leukaemias of ambiguous lineage; in Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO Press, 2008, pp 150-155.
7. Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich EJ, Stass S: Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood 1990;76:808-813. (Pubitemid 20253298)
8. Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N, Morilla R: A classification of acute leukaemia for the 1990s. Ann Hematol 1991;62:16-21.
9. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB: Proposals for the immunologic classification of acute leukemias - European Group for the Immunologic Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-1786.
10. Bene MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F, Ludwig WD, Matutes E, Orfao A, Sperling C, van't Veer MB: The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias - the European group for the immunological classification of leukemias (EGIL). Blood 1998;92:596-599. (Pubitemid 28323723)
11. Pallisgaard N, Hokland P, Riishøj DC, Pedersen B, Jørgensen P: Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998;92:574-588. (Pubitemid 28323721)
12. Xu XQ, Wang JM, Lü SQ, Chen L, Yang JM, Zhang WP, Song XM, Hou J, Ni X, Qiu HY: Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica 2009;94:919-927.
13. Carbonell F, Swansbury J, Min T, Matutes E, Farahat N, Buccheri V, Morilla R, Secker-Walker L, Catovsky D: Cytogenetic findings in acute biphenotypic leukaemia. Leukemia 1996;10:1283-1287. (Pubitemid 26261423)
14. Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, Zomas A, Atra A, Catovsky D: Outcome of biphenotypic acute leukaemia. Haematologica 1999;84:699-706.
15. Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, Ramond S, Viguié F, Marie JP, Zittoun R: Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol 1998;100:147-155. (Pubitemid 28051853)
16. Owaidah TM, Al Beihany A, Iqbal MA, Elkum N, Roberts GT: Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia 2006;20:620-626.
17. Scolnik MP, Palacios MF, Ramirez FR, Tur R, Castuma MV, Bracco MM: Trilineage phenotypic compromise in acute leukemia. Leuk Lymphoma 1999;34:395-399. (Pubitemid 29385183)
18. Yumura-Yagi K, Hara J, Kurahashi H, Okamura J, Koizumi S, Toyoda Y, Murayama N, Inoue M, Ishihara S, Tawa A: Clinical significance of CD7-positive stem cell leukemia: a distinct subtype of mixed lineage leukemia. Cancer 1991;68:2273-2280.
19. Tien HF, Wang CH: CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia. Leuk Lymphoma 1998;31:93-98.
20. Cross AH, Goorha RM, Nuss R, Behm FG, Murphy SB, Kalwinsky DK, Raimondi S, Kitchingman GR, Mirro J Jr: Acute myeloid leukemia with T lymphoid features: a distinct biologic and clinical entity. Blood 1988;72:579-587.
21. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S: Clinical importance of CD7 expression in acute myelocytic leukemia - the Japan Cooperative Group of Leukemia/Lymphoma. Blood 1993;81:2399-2405. (Pubitemid 23127077)
22. Saxena A, Sheridan DP, Card RT, McPeek AM, Mewdell CC, Skinnider LF: Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am J Hematol 1998;58:278-284. (Pubitemid 28346013)
23. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL: Prognostic value of lymphocyte surface markers in acute myeloid leu kemia. Blood 1991;77:2242-2250.
24. Kornblau SM, Thall P, Huh YO, Estey E, Andreeff M: Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance. Leukemia 1995;9:1735-1741.
25. Hanson CA, Abaza M, Sheldon S, Ross CW, Schnitzer B, Stoolman LM: Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. Br J Haematol 1993;84:49-60. (Pubitemid 23158115)
26. Gujral S, Polampalli S, Badrinath Y, Kumar A, Subramanian PG, Raje G, Amare P, Arora B, Banavali SD, Nair CN: Clinico-hematological profile in biphenotypic acute leukemia. Indian J Cancer 2009;46:160-168.
27. Kozlov I, Beason K, Yu C, Hughson M: CD79a expression in acute myeloid leukemia t (8; 21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Cancer Genet Cytogenet 2005;163:62-67. (Pubitemid 41599754)
28. He GS, Wu DP, Sun AN, Xue Y, Jin Z, Qiu H, Tang X, Miao M, Fu Z, Ma X, Wang X, Chen Z, Ruan C: B-lymphoid and myeloid lineages biphenotypic acute leukemia with t (8; 21) (q22;q22). Int J Hematol 2008;87:132-136.
29. Miyamoto T, Weissman IL, Akashi K: AML1/ETO-expressing nonleukemia stem cells in acute myelogenous leukemia with t (8; 21) chromosomal translocation. Proc Natl Acad Sci USA 2000;97:7521-7526. (Pubitemid 30431496)
30. Sulak LE, Clare CN, Morale BA, Hansen KL, Montiel MM: Biphenotypic acute leukemia in adults. Am J Clin Pathol 1990;94:54-58. (Pubitemid 20206895)
31. Aribi A, Bueso-Ramos C, Estey E, Estrov Z, O'Brien S, Giles F, Faderl S, Thomas D, Kebriaei P, Garcia-Manero G, Pierce S, Cortes J, Kantarjian H, Ravandi F: Biphenotypic acute leukaemia: a case series. Br J Haematol 2007;138:213-216. (Pubitemid 46976320)
32. Lee JH, Min YH, Chung CW, Kim BK, Yoon HJ, Jo DY, Shin HJ, Bang SM, Won JH, Zang DY, Kim HJ, Chi HS, Lee KH, Cheong JW, Kim JS, Kim SH, Park S, Park SY, Chung JS, Lee JH, Park CJ: Prognostic implications of the immunophenotype in biphenotypic acute leukemia. Leuk Lymphoma 2008;49:700-709. (Pubitemid 351517215)
33. Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, Stoppa AM, Marit G, Molina L, Michallet M: Prognostic significance of karyotype in de novo adult acute myeloid leukemia - the BGMT group. Leukemia 1995;9:1491-1498.
34. Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M, Vance GH, Cherry AM, Higgins RR, Fielding AK, Foroni L, Paietta E, Tallman MS, Litzow MR, Wiernik PH, Rowe JM, Goldstone AH, Dewald GW: Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKAL-LXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007;109:3189-3197. (Pubitemid 46572503)
35. Towatari M, Yanada M, Usui N, Takeuchi J, Sugiura I, Takeuchi M, Yagasaki F, Kawai Y, Miyawaki S, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R: Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Blood 2004;104:3507-3512. (Pubitemid 39564420)
36. Thomas DA, Faderl S, Cortes J, O'Brien S, Giles FJ, Kornblau SM, Garcia-Manero G, Keating MJ, Andreeff M, Jeha S, Beran M, Verstovsek S, Pierce S, Letvak L, Salvado A, Champlin R, Talpaz M, Kantarjian H: Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 2004;103:4396-4407. (Pubitemid 38745962)